Capital Flow Monitor · Sponsors · CIK 908259
Oncotelic Therapeutics, Inc.
29397 AGOURA ROAD, AGOURA HILLS, CA, 91301 · 650-635-7000
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$712K
Sold
$712K
% sold
100.0%
Investors
33
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | D ·current | 506(b) | $712K | $712K | 100.0% | 33 | EDGAR ↗ |
| 2025-12-11 | D | 506(b) | $12.5M | $275K | 2.2% | 4 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- VUONG TRIEU — Executive Officer / Director, AGOURA HILLS, CA
- STEVEN KING — Director, AGOURA HILLS, CA
- ANTHONY MAIDA — Executive Officer / Director, AGOURA HILLS, CA
- SHAH AMIT — Executive Officer, AGOURA HILLS, CA
- SEYMOUR FEIN — Executive Officer, AGOURA HILLS, CA
- SARAN SAUND — Executive Officer, AGOURA HILLS, CA
Placement agents
- J.h. Darbie & Co. · 0 RE raises
- N-a · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.